Zenas BioPharma, Inc. (ZBIO)

NASDAQ

$28.49

$+0.40

(+1.42%)

Regular Market

Zenas BioPharma, Inc. (ZBIO) Live Price Chart

Last updated: ⁦2026-10-21 18:56:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Zenas BioPharma, Inc. (ZBIO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $28.49, with a market capitalization of $1.74B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $13.50 to $44.60. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.74B
Open	$28.47
Day's High	$101.90
Day's Low	$5.83
Previous Close	$28.18
Volume	232.91K
Average Volume	679.83K
P/E Ratio	--
52-Week High	$44.60
52-Week Low	$13.50
Dividend Yield	--
Earnings Date	--

Zenas BioPharma, Inc. (ZBIO) Stock Price Today

Zenas BioPharma, Inc. (ZBIO) is currently trading at $28.49 as of 2026-10-21 18:55:00, up 1.10% ($0.31) from the previous close of $28.18

During today's regular trading session, ZBIO has traded between $5.83 and $101.90, with a trading volume of 232.91K shares. The current price is near the lower end of today's range.

Zenas BioPharma, Inc. (ZBIO) 7-Day Stock Price Change

Over the past seven days, Zenas BioPharma, Inc. (ZBIO) moved from $26.40 to $28.49, representing a gain of 7.92% ($2.09).

The stock traded between $24.25 and $29.71 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 560.93 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ZBIO 52-Week Price Position

Position in Range: 48.2%

52W Low$13.50

52W High$44.60

ZBIO is currently trading at $28.49, placing it 48.2% of the way from its 52-week low of $13.50 to its 52-week high of $44.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Zenas BioPharma, Inc. (ZBIO)?

Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company manages its operations on a consolidated basis as a single reportable segment focused on the research, development and commercialization of transformative immunology-based therapies.

Zenas BioPharma, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	167
Exchange	NASDAQ
Company Website	https://www.zenasbio.com

How to Buy Zenas BioPharma, Inc. (ZBIO) Stock on MEXC

Eligible investors can buy real shares of Zenas BioPharma, Inc. (ZBIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ZBIO and Place Your Order

Open the RealStocks trading page and search for ZBIO. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Zenas BioPharma, Inc. (ZBIO) stock price today?

Zenas BioPharma, Inc. (ZBIO) is currently trading at $ 28.49, up 1.10% ($0.31) from the previous close of $ 28.18. Intraday prices update in real time during regular trading hours.

2.Is ZBIO stock going up or down today?

As of 2026-10-21 18:55:00, ZBIO is trading at $ 28.49, up 1.10% ($0.31) from its previous close of $ 28.18. The stock has traded between $ 5.83 and $ 101.90 during today’s regular session. Past price movements do not guarantee future results.

3.What is ZBIO pre-market price?

As of 2026-10-21 18:55:00, ZBIO is trading at $ 28.15 in pre-market trading, down 0.12% ($0.04) from the previous close of $ 28.18. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ZBIO after-hours price?

As of 2026-10-21 18:55:00, ZBIO is trading at $ 28.15 in after-hours trading, down 0.12% ($0.04) from the regular-session close of $ 28.18. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ZBIO stock trading now?

ZBIO trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ZBIO sit relative to its 52-week high and low?

Over the past 52 weeks, ZBIO has traded between a low of $ 13.50 and a high of $ 44.60. At $ 28.49, the stock is positioned 48.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Zenas BioPharma, Inc. in?

Zenas BioPharma, Inc. (ZBIO) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Zenas BioPharma, Inc.'s market capitalization and where is it listed?

Zenas BioPharma, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.74B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ZBIO valued in terms of P/E ratio and EPS?

ZBIO trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -7.43. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Zenas BioPharma, Inc. pay a dividend?

Zenas BioPharma, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.